Capital Fund Management S.A. Crispr Therapeutics Ag Call Options Transaction History

Capital Fund Management S.A.

$33.7 Billion
Q2 2024

Call Options

15 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 13, 2024	SELL	$51.17 - $68.18 $5.28 Million - $7.03 Million	-103,100 Reduced 54.69%	85,400 $4.61 Million
Q1 2024 May 15, 2024	BUY	$60.67 - $89.12 $10.2 Million - $14.9 Million	167,300 Added 789.15%	188,500 $12.8 Million
Q4 2023 Feb 14, 2024	BUY	$38.62 - $72.18 $818,744 - $1.53 Million	21,200 New	21,200 $1.33 Million
Q2 2023 Aug 14, 2023	SELL	$43.47 - $67.77 $5.5 Million - $8.57 Million	-126,500 Reduced 84.11%	23,900 $1.34 Million
Q1 2023 May 15, 2023	BUY	$41.0 - $56.12 $2.98 Million - $4.07 Million	72,600 Added 93.32%	150,400 $6.8 Million
Q4 2022 Feb 13, 2023	BUY	$39.19 - $65.67 $1.2 Million - $2 Million	30,500 Added 64.48%	77,800 $3.16 Million
Q3 2022 Nov 14, 2022	BUY	$61.1 - $83.78 $1.07 Million - $1.47 Million	17,500 Added 58.72%	47,300 $3.09 Billion
Q2 2022 Aug 12, 2022	SELL	$43.23 - $73.83 $1.16 Million - $1.98 Million	-26,800 Reduced 47.35%	29,800 $1.81 Million
Q1 2022 May 12, 2022	BUY	$53.19 - $79.24 $1.81 Million - $2.7 Million	34,100 Added 151.56%	56,600 $3.55 Million
Q4 2021 Feb 10, 2022	SELL	$70.09 - $111.29 $4.44 Million - $7.04 Million	-63,300 Reduced 73.78%	22,500 $1.71 Million
Q1 2021 May 14, 2021	BUY	$110.72 - $210.04 $7.67 Million - $14.6 Million	69,300 Added 420.0%	85,800 $10.5 Million
Q2 2020 Aug 13, 2020	SELL	$38.5 - $76.05 $42,350 - $83,655	-1,100 Reduced 6.25%	16,500 $1.21 Million
Q1 2020 May 13, 2020	BUY	$33.68 - $62.53 $16,840 - $31,265	500 Added 2.92%	17,600 $746,000
Q4 2018 Feb 13, 2019	SELL	$22.73 - $42.34 $738,725 - $1.38 Million	-32,500 Reduced 65.52%	17,100 $489,000
Q3 2018 Nov 14, 2018	BUY	$44.35 - $65.71 $2.2 Million - $3.26 Million	49,600 New	49,600 $2.2 Million

Others Institutions Holding CRSP

# of Institutions

523

Shares Held

58M

Call Options Held

1.73M

Put Options Held

1.84M

Capital International Investors Los Angeles, CA

7.87M
Shares

$390 Million
0.09% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

7.78M
Shares

$386 Million
3.82% of portfolio
Nikko Asset Management Americas, Inc.

3.15M
Shares

$156 Million
1.99% of portfolio
Sumitomo Mitsui Trust Holdings, Inc.

3.15M
Shares

$156 Million
0.13% of portfolio
Black Rock Inc. New York, NY

2.78M
Shares

$138 Million
0.0% of portfolio

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.87B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.

Account